Bullboard Post History

by 99942Apophis

Order by:

V.TLT	Somebody has to say it! Just because we want the Newsletter Monday or even this week doesn't... March 20, 2022
V.TLT	RE:RE:RE:RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial Also thinking is if this Newsletter is really good and brings very positive... March 20, 2022
V.TLT	RE:RE:RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial Hi TimboBaggins I believe the NR patient you searched for is the same patient... March 20, 2022
V.TLT	RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial Thanks enriquesuave, tomorrow's Sunday so perhaps I can find some time... March 19, 2022
V.TLT	RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial Thanks Eoganacht good information. Speaking of a 1 year point our patient... March 19, 2022
V.TLT	RE:RE:On Breakthrough designation, ImmunityBio went for 1.4$ to 7$ chry200030 wrote That's nice but TLT is a $75 stock. forget $7. Thanks... March 17, 2022
V.TLT	RE:RE:RE:RE:Treated Patients 13 to 30 Hi DJDawg yes my calculations were done from scratch, I make my calculations... March 10, 2022
V.TLT	RE:RE:RE:Treated Patients 13 to 30 Thank you for volunteering ScienceFirst to go back and check the accuracy of... March 10, 2022
V.TLT	RE:RE:Treated Patients 13 to 30 riverrrow wrote Thanks for posting the treated patient summary. So by... March 10, 2022
V.TLT	RE:Treated Patients 13 to 30 Dates notable March 7/2022 for patients 13 & 14 hitting 450 days ... March 10, 2022
V.TLT	Treated Patients 13 to 30 fully optimized patients Patients 13 & 14 announced Dec 7/2020 1... March 10, 2022
V.TLT	RE:RE:Seem to be a few on the ask atm saw the same bid and ask on other stocks! Seems either SH has been given a... March 10, 2022
V.TLT	RE:RE:RE: Next round of financing I know who and what he is ScienceFirst thanks for your concern. He knows very... March 8, 2022
V.TLT	RE:RE: Next round of financing SouthernTierTom WHEN..and at what level? Thoughts?? Calculated estimates... March 8, 2022
V.TLT	RE:RE:RE:RE:Reading the tea leaves... Good to see of a very optimistic opinion by so many here of what this... March 8, 2022
V.TLT	RE:Reading the tea leaves... One time when I had a conversation with Kristina she brought up the subject... March 8, 2022
V.TLT	RE:RE:RE:RE:RE:Pressure on stock price................. Excellent argument for near perfect results CancerSlayer. I won't present... March 8, 2022
V.TLT	RE:RE:RE:RE:RE:DJDawg's Visualization Tool DJDawg wrote That was very confusing to me. I only found a... March 7, 2022
V.TLT	RE:RE:RE:2 points to monitor in the next round of data I don't read everyday so chances are that his post must have been one of... March 7, 2022
V.TLT	RE:RE:2 points to monitor in the next round of data Should add to my response in my opinion results for 90 day period could be... March 7, 2022

Become a member today, It's free!

Bullboard Post History

by 99942Apophis

Somebody has to say it!

RE:RE:RE:RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial

RE:RE:RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial

RE:RE:RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial

RE:12 month CR rate of ImmunityBio's N-803 in NMIBC trial

RE:RE:On Breakthrough designation, ImmunityBio went for 1.4$ to 7$

RE:RE:RE:RE:Treated Patients 13 to 30

RE:RE:RE:Treated Patients 13 to 30

RE:RE:Treated Patients 13 to 30

RE:Treated Patients 13 to 30

Treated Patients 13 to 30

RE:RE:Seem to be a few on the ask atm

RE:RE:RE: Next round of financing

RE:RE: Next round of financing

RE:RE:RE:RE:Reading the tea leaves...

RE:Reading the tea leaves...

RE:RE:RE:RE:RE:Pressure on stock price.................

RE:RE:RE:RE:RE:DJDawg's Visualization Tool

RE:RE:RE:2 points to monitor in the next round of data

RE:RE:2 points to monitor in the next round of data

Featured Company

Bank of Montreal T.BMO

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by 99942Apophis

Featured Company